Blog

May 3, 2017

CBD for neuropathic pain.

Summary: Treatment options for neuropathic pain have limited efficacy and use is fraught with dose-limiting adverse effects. The endocannabinoid system has been elucidated over the last […]
May 3, 2017

Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain.

Summary: OBJECTIVE: Debilitating pain, occurring in 50-70% of multiple sclerosis (MS) patients, is poorly understood and infrequently studied. We summarized efficacy and safety data of cannabinoid-based […]
May 3, 2017

Chemopreventive effect of CBD on experimental colon cancer.

Summary: Colon cancer affects millions of individuals in Western countries. Cannabidiol, a safe and non-psychotropic ingredient of Cannabis sativa, exerts pharmacological actions (antioxidant and intestinal antinflammatory) […]
May 3, 2017

CBD induces programmed cell death in breast cancer cells

Summary: Cannabidiol (CBD), a major nonpsychoactive constituent of cannabis, is considered an antineoplastic agent on the basis of its in vitro and in vivo activity against […]
May 3, 2017

CBD inhibits human glioma cell migration

Summary: We evaluated the ability of cannabidiol (CBD) to impair the migration of tumor cells stimulated by conditioned medium. CBD caused concentration-dependent inhibition of the migration […]
May 3, 2017

Antitumor effects of CBD, a nonpsychoactive cannabinoid

Summary: Recently, cannabinoids (CBs) have been shown to possess antitumor properties. Because the psychoactivity of cannabinoid compounds limits their medicinal usage, we undertook the present study […]
May 3, 2017

CBD inhibits cancer cell invasion

Summary: Although cannabinoids exhibit a broad variety of anticarcinogenic effects, their potential use in cancer therapy is limited by their psychoactive effects. Here we evaluated the […]
May 3, 2017

CBD as potential anticancer drug.

Summary: Over the past years, several lines of evidence support an antitumourigenic effect of cannabinoids including Δ(9)-tetrahydrocannabinol (Δ(9)-THC), synthetic agonists, endocannabinoids and endocannabinoid transport or degradation […]